BeiGene, Ltd. (BGNE)

1 member of Congress has disclosed 3 trades in BeiGene, Ltd. (BGNE) via STOCK Act filings. The most recent disclosure was a sale by Mikie Sherrill on 28 May 2019. Aggregate disclosed activity totals roughly $8K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for BGNE
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for BGNE

3 transactions
Compliance: 33%
Mikie Sherrill28 May 20198 Jul 2019SaleStock$1,001 - $15,000N/A
Mikie Sherrill28 May 201913 Aug 2020SaleStock$1,001 - $15,000N/A
Mikie Sherrill19 Feb 201913 Aug 2020PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$20.21B

Volume

329.4K

Beta

0.63

P/E Ratio

-22.55

Fundamentals

EPS

$-8.19

Div. Yield

-

Open

$184.00

Day Range

$183.91 – $187.42

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
John V. Oyler
IPO Date
2016-02-03
Website
beonemedicines.com

BeiGene, Ltd. is a global biotechnology enterprise that operates across the entire pharmaceutical value chain, encompassing the research, development, production, and worldwide commercialization of diverse therapeutic agents. The company's commercial...

Earnings

Recent Quarters

Q4 202526 Feb
EPS$0.59
Q3 202510 Nov
EPS$1.09
Q2 20255 Aug
EPS$0.84
Q3 202412 Nov
EPS$-1.15
Miss 30.7%
Q2 20247 Aug
EPS$-1.15
Beat 45.2%
Q1 20248 May
EPS$-2.41
Beat 19.1%
Q4 202326 Feb
EPS$-3.53
Miss 49.6%
Q3 20239 Nov
EPS$2.01
Beat 163.6%
Q2 20232 Aug
EPS$-3.64
Miss 12.7%
Q1 20234 May
EPS$-3.34
Beat 15.2%
Q4 202227 Feb
EPS$-4.29
Miss 1.7%
Q3 20229 Nov
EPS$-5.39
Miss 34.1%
Q2 20224 Aug
EPS$-5.56
Miss 31.4%
Q1 20225 May
EPS$-4.24
Beat 6.2%
Q4 202125 Feb
EPS$-6.16
Miss 28.6%
Q3 20214 Nov
EPS$-4.46
Beat 7.5%
Q2 20215 Aug
EPS$-5.23
Miss 41.0%
Q4 202025 Feb
EPS$-5.20
Miss 29.0%
Q3 20205 Nov
EPS$-4.81
Miss 17.0%
Q2 20206 Aug
EPS$-4.31
Beat 14.1%
Q1 202011 May
EPS$-4.70
Beat 2.7%
Q4 20192 Mar
EPS$-6.39
Miss 32.0%
Q3 201912 Nov
EPS$-5.11
Miss 43.9%
Q1 20199 May
EPS$-2.81
Beat 9.1%
Q4 201827 Feb
EPS$-4.52
Miss 57.5%
Q3 20187 Nov
EPS$-2.53
Beat 15.9%
Q1 20189 May
EPS$-2.03
Miss 3.6%
Q4 201728 Feb
EPS$-2.19
Miss 25.9%
Q3 201713 Nov
EPS$2.54
Beat 277.6%
Q2 20179 Aug
EPS$-1.52
Miss 25.6%
Q1 201710 May
EPS$-1.27
Miss 30.9%
Q3 201610 Nov
EPS$-1.08
Miss 31.7%
Q2 201610 Aug
EPS$-0.73
Miss 9.0%
Q1 201611 May
EPS$-0.97
Miss 54.0%
Q4 201530 Mar
EPS$-3.05
Miss 444.6%
Q4 20158 Feb
EPS$-0.02
Q1 201530 Jun
EPS$-0.01
Q4 201431 Mar
EPS$-0.01
Q3 201431 Dec
EPS$-0.01
Q2 201430 Sept
EPS$-0.01
Q1 201430 Jun
EPS$-0.00
Q4 201331 Mar
EPS$-0.00

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about BGNE

Which members of Congress have traded BGNE?
1 member of Congress has disclosed 3 trade in BeiGene, Ltd. (BGNE) under the STOCK Act: Mikie Sherrill.
When was BGNE most recently disclosed by Congress?
The most recent BGNE disclosure was a sale by Mikie Sherrill on 28 May 2019.
What is the total disclosed congressional trading volume for BGNE?
Members of Congress have disclosed approximately $8K in BGNE purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in BGNE?
This BGNE page updates as soon as new STOCK Act disclosures are filed for BeiGene, Ltd.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.